CXCL9 overexpression

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.

CXCL9 overexpression	Squamous Cell Carcinoma of Head and Neck	CXCL9 overexpression	Squamous Cell Carcinoma of Head and Neck	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3	pembrolizumab Sensitive: C3 – Early Trials pembrolizumab Sensitive : C3
CXCL9 overexpression	Ovarian Cancer	CXCL9 overexpression	Ovarian Cancer	PD-L1 inhibitor Sensitive: D – Preclinical PD-L1 inhibitor Sensitive : D	PD-L1 inhibitor Sensitive: D – Preclinical PD-L1 inhibitor Sensitive : D

Associations